Researchmoz added Most up-to-date research on "Behavioral Disorders Drug Development Pipeline Review, 2017" to its huge collection of research reports.
Behavioral Disorders Drug Development Pipeline Review, 2017
Summary
This report provides an overview of the behavioral disorders pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for autism, obsessive-compulsive disorder and attention deficit hyperactivity disorder and features dormant and discontinued projects.
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1343221
Autism, also known as complex developmental disability, is a neurodevelopment disorder characterized by social interaction, verbal and nonverbal communication and repetitive behaviors. Risk factors include childs sex, family history, fragile X syndrome, Tourette syndrome and epilepsy.
Obsessive-compulsive disorder (OCD) is characterized by unreasonable thoughts and fears (obsessions) that lead to do repetitive behaviors (compulsions). Symptoms include having repeated thoughts or images about many different things, such as fear of germs, dirt, or intruders, acts of violence, hurting loved ones, doing the same rituals over and over such as washing hands, locking and unlocking doors, counting, keeping unneeded items, or repeating the same steps again and again.
Finally, attention deficit hyperactivity disorder (ADHD) is a group of behavioral symptoms that include inattentiveness, hyperactivity and impulsiveness. Symptoms of ADHD include disorganized work habits, procrastination and inability to sustain attention on tasks or activities.
The size of these pipelines ranges from 8 products in obsessive-compulsive disorder to 58 products in attention deficit hyperactivity disorder. Across all three of these indications, transporters and receptors of neurotransmitters such as dopamine, glutamine and serotonin, plus G protein-coupled receptors and ion channels, are the most common targets, closely reflecting the current treatment landscape of these diseases.
Scope
- Which companies are the most active within the pipeline for behavioral disorder therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of behavioral disorders?
Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/behavioral-disorders-drug-development-pipeline-review-2017-report.html/toc
Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration
1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 Behavioral Disorders Report Coverage 8
2.2 Autism - Overview 8
2.3 Obsessive-Compulsive Disorder - Overview 8
2.4 Attention Deficit Hyperactivity Disorder (ADHD) - Overview 8
3 Therapeutics Development 9
3.1 Autism 9
3.2 Obsessive-Compulsive Disorder 17
3.3 Attention Deficit Hyperactivity Disorder (ADHD) 20
4 Therapeutics Assessment 29
4.1 Autism 29
4.2 Obsessive-Compulsive Disorder 36
4.3 Attention Deficit Hyperactivity Disorder (ADHD) 41
Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1343221
5 Companies Involved in Therapeutics Development 49
5.1 Autism 49
5.2 Obsessive-Compulsive Disorder 62
5.3 Attention Deficit Hyperactivity Disorder (ADHD) 64
6 Dormant Projects 80
6.1 Autism 80
6.2 Obsessive-Compulsive Disorder 82
6.3 Attention Deficit Hyperactivity Disorder (ADHD) 83
7 Discontinued Products 87
7.1 Autism 87
7.2 Obsessive-Compulsive Disorder 87
7.3 Attention Deficit Hyperactivity Disorder (ADHD) 88
Continue...
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on @ https://marketsizeinfo.blogspot.in/
Behavioral Disorders Drug Development Pipeline Review, 2017
Summary
This report provides an overview of the behavioral disorders pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for autism, obsessive-compulsive disorder and attention deficit hyperactivity disorder and features dormant and discontinued projects.
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1343221
Autism, also known as complex developmental disability, is a neurodevelopment disorder characterized by social interaction, verbal and nonverbal communication and repetitive behaviors. Risk factors include childs sex, family history, fragile X syndrome, Tourette syndrome and epilepsy.
Obsessive-compulsive disorder (OCD) is characterized by unreasonable thoughts and fears (obsessions) that lead to do repetitive behaviors (compulsions). Symptoms include having repeated thoughts or images about many different things, such as fear of germs, dirt, or intruders, acts of violence, hurting loved ones, doing the same rituals over and over such as washing hands, locking and unlocking doors, counting, keeping unneeded items, or repeating the same steps again and again.
Finally, attention deficit hyperactivity disorder (ADHD) is a group of behavioral symptoms that include inattentiveness, hyperactivity and impulsiveness. Symptoms of ADHD include disorganized work habits, procrastination and inability to sustain attention on tasks or activities.
The size of these pipelines ranges from 8 products in obsessive-compulsive disorder to 58 products in attention deficit hyperactivity disorder. Across all three of these indications, transporters and receptors of neurotransmitters such as dopamine, glutamine and serotonin, plus G protein-coupled receptors and ion channels, are the most common targets, closely reflecting the current treatment landscape of these diseases.
Scope
- Which companies are the most active within the pipeline for behavioral disorder therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of behavioral disorders?
Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/behavioral-disorders-drug-development-pipeline-review-2017-report.html/toc
Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration
1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 Behavioral Disorders Report Coverage 8
2.2 Autism - Overview 8
2.3 Obsessive-Compulsive Disorder - Overview 8
2.4 Attention Deficit Hyperactivity Disorder (ADHD) - Overview 8
3 Therapeutics Development 9
3.1 Autism 9
3.2 Obsessive-Compulsive Disorder 17
3.3 Attention Deficit Hyperactivity Disorder (ADHD) 20
4 Therapeutics Assessment 29
4.1 Autism 29
4.2 Obsessive-Compulsive Disorder 36
4.3 Attention Deficit Hyperactivity Disorder (ADHD) 41
Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1343221
5 Companies Involved in Therapeutics Development 49
5.1 Autism 49
5.2 Obsessive-Compulsive Disorder 62
5.3 Attention Deficit Hyperactivity Disorder (ADHD) 64
6 Dormant Projects 80
6.1 Autism 80
6.2 Obsessive-Compulsive Disorder 82
6.3 Attention Deficit Hyperactivity Disorder (ADHD) 83
7 Discontinued Products 87
7.1 Autism 87
7.2 Obsessive-Compulsive Disorder 87
7.3 Attention Deficit Hyperactivity Disorder (ADHD) 88
Continue...
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on @ https://marketsizeinfo.blogspot.in/
No comments:
Post a Comment